Application of a risk-management framework for integration of stromal Tumor Infiltrating Lymphocytes in clinical trials

Immuno-Oncology Biomarker Working Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalNPJ Breast Cancer
DOIs
Publication statusPublished - 12 May 2020

Cite this